Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic urticaria in children.

Mark Boguniewicz1

  • 1Division of Pediatric Allergy-Immunology, National Jewish Medical and Research Center, Denver, Colorado 80206, USA.

Allergy and Asthma Proceedings
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained efficacy of dupilumab in pediatric patients with moderate-to-severe atopic dermatitis over 1 year.

The British journal of dermatology·2026
Same author

Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities.

Journal of asthma and allergy·2026
Same author

Atopic dermatitis Yardstick: A new era of topical and systemic treatments.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).

Pediatric dermatology·2026
Same author

Lebrikizumab is efficacious in adults and adolescents with moderate-to-severe atopic dermatitis regardless of atopic comorbidities.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Chronic urticaria in children can be linked to autoimmune conditions and physical triggers. Further research is needed to systematically study autoantibodies and their role in pediatric chronic urticaria.

Area of Science:

  • Pediatric Allergy and Immunology
  • Dermatology
  • Autoimmunity

Background:

  • Chronic urticaria (CU) in children frequently results from physical stimuli.
  • CU can be associated with autoimmune disorders, particularly thyroid autoimmunity.
  • Functional autoantibodies targeting FcepsilonRIalpha are implicated in pediatric CU but require systematic investigation.

Purpose of the Study:

  • To systematically investigate functional autoantibodies against FcepsilonRIalpha in children with chronic urticaria.
  • To evaluate the utility of the autologous serum skin test as a surrogate marker for these autoantibodies.

Main Methods:

  • Systematic review and analysis of existing literature on autoantibodies in pediatric CU.
  • Evaluation of the autologous serum skin test's diagnostic accuracy for detecting histamine-releasing factors versus specific antibodies.

Related Experiment Videos

Main Results:

  • Functional autoantibodies against FcepsilonRIalpha are reported in children with CU.
  • The autologous serum skin test may indicate histamine-releasing factors, not definitively antibodies.
  • Second-generation antihistamines are standard treatment; leukotriene receptor antagonists may benefit some patients.

Conclusions:

  • Autoimmunity, specifically autoantibodies against FcepsilonRIalpha, is a potential factor in pediatric chronic urticaria.
  • The autologous serum skin test requires careful interpretation in the context of autoantibody detection.
  • Current therapeutic strategies include antihistamines and potentially leukotriene receptor antagonists.